Zepp Health Corporation
ZEPPTechnologyNASDAQConsumer Electronics
Scan Results
Daily timeframeZepp Health Corporation operates as a smart wearable and health technology company worldwide. The $70.4M market capitalization puts ZEPP squarely in micro-cap range for its industry. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Market Cap
$70.4M
Beta
—
P/E (TTM)
—
P/E (Fwd)
96.00
EPS (TTM)
$-6.24
EPS (Fwd)
$0.05
ROE
-21.2%
ROA
-3.9%
Cash
$69.7M
Total Debt
$134.3M
Free CF
—
52W Change
-90.6%
Annual Financials
Cash vs Debt
Where ZEPP stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ZEPP finished 56.57% below its 150-day moving average ($11.19) and 67.71% below its 200-day moving average ($15.05). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ZEPP overbought or oversold?
At the September 3, 2026 close, ZEPP's RSI(14) was 40.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ZEPP has $69.7M in cash with $134.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. ROE of -21.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $613.6M (2022) to $258.9M (2025), a 58% decline worth watching.
Investors considering Zepp Health Corporation should weigh the typical risks associated with ZEPP's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ZEPP.